Perioperative antimicrobial therapy for pancreatoduodenectomy

Savio G. Barreto, Manish K. Singh, Sunil Sharma, Adarsh Chaudhary

Research output: Contribution to journalMeeting Abstractpeer-review


Objectives: Infectious complications occur in upto 45% of patients following pancreatoduodenectomy (PD) and are higher in patients undergoing preoperative endoscopic invasive procedures. Surgical morbidity adversely affects long-term outcomes and thus role of perioperative antimicrobials needs evaluation. The aim of the study was to compare the impact of Ertapenem administered as 3-once daily perioperative doses on infectious complications in patients at high-risk for complications (underwent preoperative invasive endoscopic procedures) versus those at low-risk (up-front surgery).
Original languageEnglish
Pages (from-to)e418
Number of pages1
Issue numberSupplement 1
Publication statusPublished - Apr 2016
Externally publishedYes


  • Perioperative
  • antimicrobial
  • therapy
  • pancreatoduodenectomy


Dive into the research topics of 'Perioperative antimicrobial therapy for pancreatoduodenectomy'. Together they form a unique fingerprint.

Cite this